We’re delighted to announce that R-S-S will be attending ISPOR Europe 2025, taking place from 9–12 November in Glasgow, Scotland.
As one of the world’s leading events for health economics and outcomes research (HEOR), this year’s conference will bring together global healthcare leaders, researchers, and decision-makers to explore how collaboration can drive value and improve patient access to innovative treatments.
Watch a Live Demo of ECLIPTICA®: AI-Driven Synthetic Data for Safer, Smarter Research
Join us at our booth 316 for a live demo of ECLIPTICA®. We’ll share how our latest innovation – ECLIPTICA® – uses state of the art Gen AI methods to generate synthetic data at the click of a few buttons.
It’s time to eliminate data restrictions and redefine the possibilities for orphan disease applications, real-world evidence, market access and beyond!
Powering Value and Access Through Patient-Centred Collaboration
The theme of the conference, “Powering Value and Access Through Patient-Centred Collaboration,” echoes our mission here at R-S-S. The healthcare ecosystem is evolving fast, from increasing cost pressures to complex regulatory frameworks and groundbreaking innovations, and now more than ever, the industry must work together to achieve meaningful outcomes for patients.
The conference will focus on how integrating patient perspectives into value assessment, pricing, reimbursement, and market access strategies can create more equitable and sustainable healthcare systems. We’re looking forward to learning about the latest advancements in HEOR that are shaping the future of value-based healthcare.
Meet us in Glasgow
We’re excited to join the conversation at ISPOR Europe 2025, sharing how our expertise in HEOR, regulatory science, and market access can support smarter, faster, and more reliable pathways to bring new therapies to patients.
If you’re attending ISPOR Europe 2025, we’d love to connect. Come and meet the R-S-S team at booth 316 to learn more about how we’re helping pharmaceutical partners navigate the scientific and regulatory complexities of drug development, and how together, we can advance healthcare value and access for all.
Stay tuned for updates as we prepare for this exciting event in Glasgow!